Repatha 420 mg/3.5 mL single-dose Pushtronex® system Images
Generic Name: evolocumab
This medication has been identified as Repatha 420 mg/3.5 mL single-dose Pushtronex® system. It is supplied by Amgen Inc.
Repatha is used in the treatment of High Cholesterol, Familial Heterozygous; Cardiovascular Risk Reduction; High Cholesterol, Familial Homozygous; High Cholesterol and belongs to the drug class PCSK9 inhibitors. Repatha 420 mg/3.5 mL single-dose Pushtronex® system is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Repatha
- Generic Name
- evolocumab
- Strength
- 420 mg/3.5 mL single-dose Pushtronex® system
- Availability
- Prescription only
- Drug Class
- PCSK9 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0770 (Discontinued)
See also:
Lipitor
Lipitor is used to treat high cholesterol. Learn about side effects, interactions and indications.
Crestor
Crestor (rosuvastatin) is used to treat high cholesterol and high triglycerides in the blood ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zetia
Zetia (ezetimibe) is used to treat high cholesterol. Includes Zetia side effects, interactions and ...
Zocor
Zocor (simvastatin) reduces low-density lipoprotein cholesterol and total cholesterol in the blood ...
Praluent
Praluent (alirocumab) is an injectable medicine that is given under your skin which may be used in ...
Lovastatin
Lovastatin is used for high cholesterol, high cholesterol, familial heterozygous ...
Pravastatin
Pravastatin (Pravachol) is a statin medicine used to lower cholesterol and triglycerides in the ...
Simvastatin
Simvastatin (Zocor) is a cholesterol-lowering medication that blocks the production of cholesterol ...
More about Repatha (evolocumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (705)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: PCSK9 inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.